Information and guidance from across SPS on pharmaceutical aspects of COVID-19 vaccines’ use

Higher temperatures increase risks to safe vaccine use and storage. To minimise effects: control ambient temperature, assess risks, and mitigate against them.
Dose scheduling, actions when the intervals are longer than or less than recommended, and use of alternative brands for second doses
ANTT minimises the risk of contamination transfer to critical surfaces. It should be used during vaccine preparation and assembly.
The MHRA published revised advice on stability on 20 May 2021. Changing the expiry date of existing supply may be needed in the immediate following period.